Gateway 2012: Perfex - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2012: Perfex


Perfex Corporation
32 Case Street
Poland, NY 13431
Toll Free: 800-848-8483, Fax: 315-826-7471
Perfex@PerfexOnline.com
www.PerfexOnline.com

Perfex Corporation has become the nation’s principal manufacturer of unique and innovative cleaning tools designed for controlled environments. Our products are designed to be cost effective, easy to use, as well as heat, bacteria and chemical resistant. TruCLEAN™ Cleaning Systems isolate contaminants to ensure the delivery of unadulterated cleaning agents. Constructed of high-grade stainless steel, TruCLEAN Components are easy to maintain and compatible with gamma, ETO and autoclave sterilization. PERFEX manufactures Cleanroom Mopping Systems, Microfiber Mops, Sponge Mops, Brooms, Brushes and also a full line of sanitary handling products including Scoops, Shovels and Scrapers. Please call or email for your new catalog.

The TruCLEAN Pro captures and isolates contaminants, ensuring delivery of unadulterated cleaning and sanitizing agents. No more re-applying dirty water or weakened solutions, experienced with old-style mopping supplies. TruCLEAN Pro is compatible with gamma, ETO and autoclave sterilization. Available in double or triple-bucket design. Item #22-3.

The TruCLEAN II has a unique bucket-in-bucket concept that works to isolate soiled contaminants from cleaning and disinfecting agents. Avoid high costs and risk of run-off contaminants common with steam-sterilizers. TruCLEAN Components are constructed of high-grade stainless steel, easy to maintain and guaranteed to deliver reliable cleaning results time after time. Compatible with Gamma, ETO and autoclave sterilization. Item #30-2.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here